Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15961763 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Geldanamycin Analogue in Treating Patients With Advanced Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: tanespimycin

Indicates status has not been verified in more than two years